Ataibeckley INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ

11 Sept 2026

ATAI

Ataibeckley INC

8-K: AtaiBeckley Inc. Merger with Eli Lilly Completed

AtaiBeckley Inc. has been acquired by Eli Lilly and Company, with shareholders receiving $6.75 in cash and a contingent value right per share.

NASDAQ

8 Sept 2026

ATAI

Ataibeckley INC

8-K: AtaiBeckley Shareholders Approve Eli Lilly Merger

AtaiBeckley Inc. announced the overwhelming approval of its merger with Eli Lilly and Company by its shareholders, paving the way for a September 11, 2026, closing.

NASDAQ

31 Aug 2026

ATAI

Ataibeckley INC

8-K: AtaiBeckley Merger Progresses: Antitrust Review Expires

AtaiBeckley Inc. reports that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for its merger with Eli Lilly and Company has expired, signaling continued progress towards the transaction's completion.

NASDAQ

16 Jul 2026

ATAI

Ataibeckley INC

8-K: Eli Lilly to Acquire AtaiBeckley for $6.75/share + CVRs

Eli Lilly and Company announced a definitive agreement to acquire AtaiBeckley Inc. for $6.75 per share in cash plus a contingent value right (CVR) for potential future payments.